Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Injectable Anticoagulants Market 2018, Forecast to 2023
- July 2018
- 137 pages
Scope of the Report:
This report focuses on the Injectable Anticoagulants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.
Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.
The worldwide market for Injectable Anticoagulants is expected to grow at a CAGR of roughly 2.7% over the next five years, will reach 6440 million US$ in 2023, from 5490 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
The Medicines Company
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Injectable Anticoagulants market.
Chapter 1, to describe Injectable Anticoagulants Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Injectable Anticoagulants, with sales, revenue, and price of Injectable Anticoagulants, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Injectable Anticoagulants, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Injectable Anticoagulants market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Injectable Anticoagulants sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Have query on this report?Make an Enquiry
1 Market Overview
1.1 Injectable Anticoagulants Introduction
1.2 Market Analysis by Type
1.2.1 Low-molecular-weight Heparin (LMWH)
Figure Injectable Anticoagulants Picture
Table Product Specifications of Injectable Anticoagulants
Figure Global Injectable Anticoagulants CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Injectable Anticoagulants CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Injectable Anticoagulants by Types in 2017
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017